Natco Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has informed the stock exchanges that the trading window for dealing in its securities will be closed from October 1, 2025, until 48 hours after the declaration of financial results for the quarter ending September 30, 2025 (Q2 FY26). The closure applies to directors, designated persons, their immediate relatives, and all other connected persons under the company's insider trading code. The date of the board meeting to approve these quarterly results will be announced separately in due course.
This is a routine compliance announcement under SEBI insider trading norms and signals that the company is preparing to announce its Q2 FY26 results soon. It has no direct impact on the stock price but temporarily restricts insider trading activity ahead of the results declaration.